These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 4186337

  • 1. Adrenocortical suppression with small doses of topical corticosteroids.
    Carr RD, Belcher RW.
    Acta Derm Venereol; 1969; 49(5):508-13. PubMed ID: 4186337
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Topical corticosteroids for skin disorders.
    Med Lett Drugs Ther; 1966 May 20; 8(10):37-8. PubMed ID: 4223426
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relative potency of percutaneously absorbed corticosteroids in the suppression of pituitary-adrenal function.
    Scoggins RB, Kliman B.
    J Invest Dermatol; 1965 Nov 20; 45(5):347-55. PubMed ID: 5321337
    [No Abstract] [Full Text] [Related]

  • 7. [Comparative studies on the vasoconstrictor effect of various corticosteroids].
    Bickhardt R.
    Hautarzt; 1972 Jul 20; 23(7):301-5. PubMed ID: 4655109
    [No Abstract] [Full Text] [Related]

  • 8. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW, Woodford R.
    Br J Dermatol; 1974 Sep 20; 91(3):323-38. PubMed ID: 4611447
    [No Abstract] [Full Text] [Related]

  • 9. The influence of corticosteroids, griseofulvin and tolnaftate on the in vitro growth of two dermatophytes.
    Caplan RM, Clabaugh W.
    J Invest Dermatol; 1969 Mar 20; 52(3):247-54. PubMed ID: 5774352
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The absorption of topical corticosteroids, with particular reference to percutaneous absorption in infancy and childhood.
    Keipert JA.
    Med J Aust; 1971 May 08; 1(19):1021-5. PubMed ID: 4930660
    [No Abstract] [Full Text] [Related]

  • 14. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
    Winter GD, Wilson L.
    Br J Dermatol; 1976 May 08; 94(5):545-50. PubMed ID: 1268065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Corticosteroids and adrenal function.
    JAMA; 1969 Sep 15; 209(11):1713. PubMed ID: 5820170
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Percutaneous absorption of corticosteroids. Adrenocortical suppression with total body inunction.
    Carr RD, Tarnowski WM.
    Acta Derm Venereol; 1968 Sep 15; 48(5):417-28. PubMed ID: 4177565
    [No Abstract] [Full Text] [Related]

  • 19. Effect of hydrocortisone acetate, fluocinolone acetonide, fluclorolone acetonide, betamethasone-17-valerate and fluprednyliden-21-acetate on collagen biosynthesis.
    Uitto J, Mustakallio KK.
    Biochem Pharmacol; 1971 Sep 15; 20(9):2495-503. PubMed ID: 4355785
    [No Abstract] [Full Text] [Related]

  • 20. [Corticotropo-corticoadrenal dynamics in prolonged cortisone treatment].
    Ferrari E, Bossolo PA, Pallavicini S, Personeni G.
    Folia Endocrinol; 1967 Oct 15; 20(5):581-96. PubMed ID: 4298865
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.